Transcription factor toolkit for targeted activation of specialized metabolite biosynthesis in plants

Overview

This solution leverages the discovery that transcription factors governing the biosynthesis of specialized metabolites are transcriptionally co-expressed with the enzymes that produce those metabolites. By identifying and over-expressing these master regulator transcription factors, it becomes possible to induce the coordinated production of beneficial metabolites through the manipulation of a single gene. This approach offers a streamlined route to activating complex metabolic pathways in plants, with observed relevance across multiple species including Arabidopsis, Artemisia, tomato, tobacco, and Selaginella. The technology is relevant to industries seeking novel bioactive compounds for pharmaceutical, nutraceutical, and agricultural applications.

Technical specifications

Key features:

• Identifies transcription factors co-expressed with target metabolic pathways using transcriptomic co-expression analysis
• Over-expression of selected transcription factors triggers coordinated up-regulation of pathway enzymes
• Enables spatio-temporal control of metabolite production by modifying a single regulatory gene
• Validated across multiple plant species, supporting broad applicability
• Transient transformation via leaf infiltration in Nicotiana benthamiana serves as a rapid validation platform
• RNA sequencing is used to confirm predicted transcriptional targets and pathway activation

How it works:

The methodology begins with computational identification of transcription factors whose expression patterns correlate with enzymes in a pathway of interest. Candidate transcription factors are then over-expressed in plant tissue, and RNA sequencing is used to verify whether the predicted downstream enzymes and pathway components are up-regulated, confirming pathway activation.

Technology readiness level

The underlying co-expression relationship between transcription factors and metabolic pathway enzymes has been validated through published analyses across several plant species. The next stage of development involves identifying transcription factors co-expressed with selected metabolic pathways in tobacco, validating them through transient over-expression in Nicotiana benthamiana, and confirming target gene activation via RNA sequencing. This places the technology at an early-to-mid stage of development, with proof-of-concept established and active pathway-specific validation underway.